![](/img/cover-not-exists.png)
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study
Havrdova, E., Giovannoni, G., Stefoski, D., Forster, S., Umans, K., Mehta, L., Greenberg, S., Elkins, J.Volume:
20
Language:
english
Journal:
Multiple Sclerosis Journal
DOI:
10.1177/1352458513502113
Date:
April, 2014
File:
PDF, 959 KB
english, 2014